Vascular endothelial growth factor inhibitors and cognitive impairment: evidence and controversies

Bibliography

• Schagen SB, Vardy J. Cognitive dysfunction in people with cancer. Lancet Oncol 2007;8:852-3
   PubMed Web of Science ®Google Scholar
• Vardy J. Cognitive function in breast cancer survivors. Cancer Treat Res 2009;151:387-419
   PubMedGoogle Scholar
• Hurria A, Somlo G, Ahles T. Renaming ‘‘chemobrain''. Cancer Invest 2007;25:373-7
   PubMed Web of Science ®Google Scholar
• Cheung YT, Shwe M, Tan YP, et al. Cognitive changes in multiethnic Asian breast cancer patients: a focus group study. Ann Oncol 2012;10:2547-52
   Google Scholar
• Cheung YT, Shwe M, Chui WK, et al. Effects of chemotherapy and psychosocial distress on perceived cognitive disturbances in asian breast cancer patients. Ann Pharmacother 2012;46:1645-55
   PubMed Web of Science ®Google Scholar
• Cheung YT, Chui WK, Chan A. Neuro-cognitive impairment in breast cancer patients: pharmacological considerations. Crit Rev Oncol Hematol 2012;83:99-111
   PubMed Web of Science ®Google Scholar
• Pullens MJ, De Vries J, Roukema JA. Subjective cognitive dysfunction in breast cancer patients: a systematic review. Psychooncology 2010;19:1127-38
   PubMed Web of Science ®Google Scholar
• Reid-Arndt SA, Hsieh C, Perry MC. Neuropsychological functioning and quality of life during the first year after completing chemotherapy for breast cancer. Psychooncology 2010;19:535-44
   PubMed Web of Science ®Google Scholar
• Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003;9:669-76
   PubMed Web of Science ®Google Scholar
• Mackenzie F, Ruhrberg C. Diverse roles for VEGF-A in the nervous system. Development 2012;139:1371-80
   PubMed Web of Science ®Google Scholar
• Ruiz de Almodovar C, Lambrechts D, Mazzone M, et al. Role and therapeutic potential of VEGF in the nervous system. Physiol Rev 2009;89:607-48
   PubMed Web of Science ®Google Scholar
• Shojaei F. Anti-angiogenesis therapy in cancer: current challenges and future perspectives. Cancer Lett 2012;320:130-7
   PubMed Web of Science ®Google Scholar
• Cook KM, Figg WD. Angiogenesis inhibitors: current strategies and future prospects. CA Cancer J Clin 2010;60:222-43
   PubMed Web of Science ®Google Scholar
• Palmer TD, Willhoite AR, Gage FH. Vascular niche for adult hippocampal neurogenesis. J Comp Neurol 2000;425:479-94
   PubMed Web of Science ®Google Scholar
• Shen Q, Goderie SK, Jin L, et al. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 2004;304:1338-40
   PubMed Web of Science ®Google Scholar
• Bao X, Wei J, Feng M, et al. Transplantation of human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and endogenous neurogenesis after cerebral ischemia in rats. Brain Res 2011;1367:103-13
   PubMed Web of Science ®Google Scholar
• Cao L, Jiao X, Zuzga DS, et al. VEGF links hippocampal activity with neurogenesis, learning and memory. Nat Genet 2004;36:827-35
   PubMed Web of Science ®Google Scholar
• Wong-Goodrich SJ, Pfau ML, Flores CT, et al. Voluntary running prevents progressive memory decline and increases adult hippocampal neurogenesis and growth factor expression after whole-brain irradiation. Cancer Res 2010;70:9329-38
   PubMed Web of Science ®Google Scholar
• Olsson AK, Dimberg A, Kreuger J, et al. VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol 2006;7:359-71
   PubMed Web of Science ®Google Scholar
• Banks WA. Characteristics of compounds that cross the blood-brain barrier. BMC Neurol 2009;9:S3
   PubMed Web of Science ®Google Scholar
• Fabel K, Fabel K, Tam B, et al. VEGF is necessary for exercise-induced adult hippocampal neurogenesis. Eur J Neurosci 2003;18:2803-12
   PubMed Web of Science ®Google Scholar
• Kim BW, Choi M, Kim YS, et al. Vascular endothelial growth factor (VEGF) signaling regulates hippocampal neurons by elevation of intracellular calcium and activation of calcium/calmodulin protein kinase II and mammalian target of rapamycin. Cell Signal 2008;20:714-25
   Google Scholar
• Licht T, Goshen I, Avital A, et al. Reversible modulations of neuronal plasticity by VEGF. Proc Natl Acad Sci USA 2011;108:5081-6
   PubMed Web of Science ®Google Scholar
• Sun Y, Jin K, Childs JT, et al. Vascular endothelial growth factor-B (VEGFB) stimulates neurogenesis: evidence from knockout mice and growth factor administration. Dev Biol 2006;289:329-35
   Google Scholar
• Calvo CF, Fontaine RH, Soueid J, et al. Vascular endothelial growth factor receptor 3 directly regulates murine neurogenesis. Genes Dev 2011;25:831-44
   PubMed Web of Science ®Google Scholar
• Dobrogowska DH, Lossinsky AS, Tarnawski M, et al. Increased blood-brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor. J Neurocytol 1998;27:163-73
   PubMedGoogle Scholar
• Byrne AM, Bouchier-Hayes DJ, Harmey JH. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med 2005;9:777-94
   PubMed Web of Science ®Google Scholar
• Ruitenberg A, den Heijer T, Bakker SL, et al. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol 2005;57:789-94
   PubMed Web of Science ®Google Scholar
• Poels MM, Ikram MA, Vernooij MW, et al. Total cerebral blood flow in relation to cognitive function: the Rotterdam Scan Study. J Cereb Blood Flow Metab 2008;28:1652-5
   PubMed Web of Science ®Google Scholar
• Austin BP, Nair VA, Meier TB, et al. Effects of hypoperfusion in Alzheimer's disease. J Alzheimers Dis 2011;26 Suppl 3:123-33
   PubMed Web of Science ®Google Scholar
• Kalaria RN, Cohen DL, Premkumar DR, et al. Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia. Brain Res Mol Brain Res 1998;62:101-5
   PubMedGoogle Scholar
• Hai J, Li ST, Lin Q, et al. Vascular endothelial growth factor expression and angiogenesis induced by chronic cerebral hypoperfusion in rat brain. Neurosurgery 2003;53:963-70; discussion 70-2
   PubMed Web of Science ®Google Scholar
• Wang P, Xie ZH, Guo YJ, et al. VEGF-induced angiogenesis ameliorates the memory impairment in APP transgenic mouse model of Alzheimer's disease. Biochem Biophys Res Commun 2011;411:620-6
   PubMed Web of Science ®Google Scholar
• Yang SP, Bae DG, Kang HJ, et al. Co-accumulation of vascular endothelial growth factor with beta-amyloid in the brain of patients with Alzheimer's disease. Neurobiol Aging 2004;25:283-90
   PubMed Web of Science ®Google Scholar
• Deng W, Aimone JB, Gage FH. New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory? Nat Rev Neurosci 2010;11:339-50
   PubMed Web of Science ®Google Scholar
• Couillard-Despres S, Iglseder B, Aigner L. Neurogenesis, cellular plasticity and cognition: the impact of stem cells in the adult and aging brain--a mini-review. Gerontology 2011;57:559-64
   PubMed Web of Science ®Google Scholar
• Izquierdo I, Medina JH. Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain structures. Neurobiol Learn Mem 1997;68:285-316
   PubMed Web of Science ®Google Scholar
• Eichenbaum H. A cortical-hippocampal system for declarative memory. Nat Rev Neurosci 2000;1:41-50
   PubMed Web of Science ®Google Scholar
• Eichenbaum H. The hippocampus and declarative memory: cognitive mechanisms and neural codes. Behav Brain Res 2001;127:199-207
   PubMed Web of Science ®Google Scholar
• Morris RG. Elements of a neurobiological theory of hippocampal function: the role of synaptic plasticity, synaptic tagging and schemas. Eur J Neurosci 2006;23:2829-46
   PubMed Web of Science ®Google Scholar
• Koehl M, Abrous DN. A new chapter in the field of memory: adult hippocampal neurogenesis. Eur J Neurosci 2011;33:1101-14
   PubMed Web of Science ®Google Scholar
• Sahay A, Hen R. Adult hippocampal neurogenesis in depression. Nat Neurosci 2007;10:1110-15
   PubMed Web of Science ®Google Scholar
• Sahay A, Scobie KN, Hill AS, et al. Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation. Nature 2011;472:466-70
   PubMed Web of Science ®Google Scholar
• Plaschke K, Staub J, Ernst E, et al. VEGF overexpression improves mice cognitive abilities after unilateral common carotid artery occlusion. Exp Neurol 2008;214:285-92
   PubMed Web of Science ®Google Scholar
• Michalczyk K, Ziman M. Nestin structure and predicted function in cellular cytoskeletal organisation. Histol Histopathol 2005;20:665-71
   PubMed Web of Science ®Google Scholar
• Benjamin LE, Hemo I, Keshet E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 1998;125:1591-8
   PubMed Web of Science ®Google Scholar
• Cameron HA, Hazel TG, McKay RD. Regulation of neurogenesis by growth factors and neurotransmitters. J Neurobiol 1998;36:287-306
   PubMedGoogle Scholar
• Lee E, Son H. Adult hippocampal neurogenesis and related neurotrophic factors. BMB Rep 2009;42:239-44
   PubMed Web of Science ®Google Scholar
• Bliss TV, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993;361:31-9
   PubMed Web of Science ®Google Scholar
• Cooke SF, Bliss TV. Plasticity in the human central nervous system. Brain 2006;129:1659-73
   PubMed Web of Science ®Google Scholar
• Pati S, Orsi SA, Moore AN, et al. Intra-hippocampal administration of the VEGF receptor blocker PTK787/ZK222584 impairs long-term memory. Brain Res 2009;1256:85-91
   PubMed Web of Science ®Google Scholar
• van der Veldt AA, van den Eertwegh AJ, Hoekman K, et al. Reversible cognitive disorders after sunitinib for advanced renal cell cancer in patients with preexisting arteriosclerotic leukoencephalopathy. Ann Oncol 2007;18:1747-50
   PubMed Web of Science ®Google Scholar
• Schuff N, Matsumoto S, Kmiecik J, et al. Cerebral blood flow in ischemic vascular dementia and Alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging. Alzheimers Dement 2009;5:454-62
   PubMed Web of Science ®Google Scholar
• Mulder SF, Bertens D, Vissers KCP, et al. Impairment of cognitive functioning during sunitinib or sorafenibtreatment−a cross sectional study. Eur J Cancer 2011;47:S514; Po7132
   Google Scholar
• Noal S, Lange M, Escudier B, et al. Fatigue, quality of life, and cognitive functions in metastatic kidney cancer patients with antiangiogenic treatment. Ann Oncol 2010;21:S8, viii298; abstract 950
   Google Scholar
• AVASTIN® (bevacizumab). Genentech, Inc; South San Francisco, CA: 2012
   Google Scholar
• Friedman HS, Prados MD, Wen PY, et al. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol 2009;27:4733-40
   PubMed Web of Science ®Google Scholar
• Kreisl TN, Kim L, Moore K, et al. Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. J Clin Oncol 2009;27:740-5
   PubMed Web of Science ®Google Scholar
• Tang SC, Lagas JS, Lankheet NA, et al. Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration. Int J Cancer 2012;130:223-33
   PubMed Web of Science ®Google Scholar
• Tang SC, Lankheet NA, Poller B, et al. P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) restrict brain accumulation of the active sunitinib metabolite N-desethyl sunitinib. J Pharmacol Exp Ther 2012;341:164-73
   PubMed Web of Science ®Google Scholar
• Boykoff N, Moieni M, Subramanian SK. Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response. J Cancer Surviv 2009;3:223-32
   PubMed Web of Science ®Google Scholar
• Debess J, Riis JO, Engebjerg MC, et al. Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study. Breast Cancer Res Treat 2010;121:91-100
   PubMed Web of Science ®Google Scholar
• Bender CM, Sereika SM, Berga SL, et al. Cognitive impairment associated with adjuvant therapy in breast cancer. Psychooncology 2006;15:422-30
   PubMed Web of Science ®Google Scholar
• Ahles TA, Saykin AJ, McDonald BC, et al. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol 2010;28:4434-40
   PubMed Web of Science ®Google Scholar
• Hermelink K, Untch M, Lux MP, et al. Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer 2007;109:1905-13
   PubMed Web of Science ®Google Scholar
• Jansen CE, Cooper BA, Dodd MJ, et al. A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Support Care Cancer 2011;19:1647-56
   PubMed Web of Science ®Google Scholar
• Jansen CE, Dodd MJ, Miaskowski CA, et al. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide. Psychooncology 2008;17:1189-95
   PubMed Web of Science ®Google Scholar
• Jenkins V, Shilling V, Deutsch G, et al. A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 2006;94:828-34
   PubMed Web of Science ®Google Scholar
• Jim HS, Donovan KA, Small BJ, et al. Cognitive functioning in breast cancer survivors: a controlled comparison. Cancer 2009;115:1776-83
   PubMed Web of Science ®Google Scholar
• Mehlsen M, Pedersen AD, Jensen AB, et al. No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy. Psychooncology 2009;18:248-57
   PubMed Web of Science ®Google Scholar
• Quesnel C, Savard J, Ivers H. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study. Breast Cancer Res Treat 2009;116:113-23
   PubMed Web of Science ®Google Scholar
• Schagen SB, Muller MJ, Boogerd W, et al. Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. J Natl Cancer Inst 2006;98:1742-5
   PubMed Web of Science ®Google Scholar
• Stewart A, Collins B, Mackenzie J, et al. The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study. Psychooncology 2008;17:122-30
   PubMed Web of Science ®Google Scholar
• Tchen N, Juffs HG, Downie FP, et al. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 2003;21:4175-83
   PubMed Web of Science ®Google Scholar
• Tager FA, McKinley PS, Schnabel FR, et al. The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study. Breast Cancer Res Treat 2010;123:25-34
   PubMed Web of Science ®Google Scholar
• van Dam FS, Schagen SB, Muller MJ, et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 1998;90:210-18
   PubMed Web of Science ®Google Scholar
• Wefel JS, Lenzi R, Theriault RL, et al. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 2004;100:2292-9
   PubMed Web of Science ®Google Scholar
• Wefel JS, Vardy J, Ahles T, et al. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 2011;12:703-8
   PubMed Web of Science ®Google Scholar
• Holmes D. Trying to unravel the mysteries of chemobrain. Lancet Neurol 2013;12(6):533-4
   PubMedGoogle Scholar
• Asher A. Cognitive dysfunction among cancer survivors. Am J Phys Med Rehabil 2011;90:S16-26
   PubMedGoogle Scholar
• Ahles TA, Saykin AJ, McDonald BC, et al. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol 2010;28:4434-40
   PubMed Web of Science ®Google Scholar
• O'Connor JP, Jackson A, Asselin MC, et al. Quantitative imaging biomarkers in the clinical development of targeted therapeutics: current and future perspectives. Lancet Oncol 2008;9:766-76
   PubMed Web of Science ®Google Scholar
• Peterson B, Summergrad P. Binswanger's disease (Part II): pathogenesis of subcortical arteriosclerotic encephalopathy and its relation to other dementing processes. J Geriatr Psychiatry Neurol 1989;2:171-81
   PubMedGoogle Scholar
• Leritz EC, McGlinchey RE, Kellison I, et al. Cardiovascular disease risk factors and cognition in the elderly. Curr Cardiovasc Risk Rep 2011;5:407-12
   PubMedGoogle Scholar
• Del Bo R, Ghezzi S, Scarpini E, et al. VEGF genetic variability is associated with increased risk of developing Alzheimer's disease. J Neurol Sci 2009;283:66-8
   PubMed Web of Science ®Google Scholar
• Del Bo R, Scarlato M, Ghezzi S, et al. Vascular endothelial growth factor gene variability is associated with increased risk for AD. Ann Neurol 2005;57:373-80
   PubMed Web of Science ®Google Scholar
• Chiappelli M, Borroni B, Archetti S, et al. VEGF gene and phenotype relation with Alzheimer's disease and mild cognitive impairment. Rejuvenation Res 2006;9:485-93
   PubMed Web of Science ®Google Scholar
• Chapuis J, Tian J, Shi J, et al. Association study of the vascular endothelial growth factor gene with the risk of developing Alzheimer's disease. Neurobiol Aging 2006;27:1212-15
   PubMed Web of Science ®Google Scholar
• Mateo I, Llorca J, Infante J, et al. Case-control study of vascular endothelial growth factor (VEGF) genetic variability in Alzheimer's disease. Neurosci Lett 2006;401:171-3
   PubMed Web of Science ®Google Scholar
• SUTENT® (sunitinib malate). Pfizer Inc., New York, NY: 2012
   Google Scholar
• Patyna S, Peng J. Distribution of sunitinib and its active metabolite in brain and spinal cord tissue following oral or intravenous administration in rodents and monkeys [abstract 56]. Eur J Cancer 2006;4:21
   Google Scholar
• Thibault F, Billemont B, Rixe O. Regression of brain metastases of renal cell carcinoma with antiangiogenic therapy. J Neurooncol 2008;86:243-4
   PubMed Web of Science ®Google Scholar
• Zeng H, Li X, Yao J, et al. Multifocal brain metastases in clear cell renal cell carcinoma with complete response to sunitinib. Urol Int 2009;83:482-5
   PubMed Web of Science ®Google Scholar
• Koutras AK, Krikelis D, Alexandrou N, et al. Brain metastasis in renal cell cancer responding to sunitinib. Anticancer Res 2007;27:4255-7
   PubMed Web of Science ®Google Scholar
• Medioni J, Cojocarasu O, Belcaceres JL, et al. Complete cerebral response with sunitinib for metastatic renal cell carcinoma. Ann Oncol 2007;18:1282-3
   PubMed Web of Science ®Google Scholar
• NEXAVAR® (sorafenib). Bayer Pharmaceuticals Corp; West Haven, CT: 2011
   Google Scholar
• Kim A, McCully C, Cruz R, et al. The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primates. Invest New Drugs 2012;30:524-8
   Google Scholar
• Agarwal MM, Khandelwal N, Mandal AK, et al. Factors affecting bone mineral density in patients with prostate carcinoma before and after orchidectomy. Cancer 2005;103:2042-52
   PubMed Web of Science ®Google Scholar
• Agarwal S, Elmquist WF. Insight into the cooperation of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) at the blood–brain barrier: a case study examining sorafenib efflux clearance. Mol Pharm 2012;9:678-84
   PubMed Web of Science ®Google Scholar
• Minocha M, Khurana V, Qin B, et al. Enhanced brain accumulation of pazopanib by modulating P-gp and Bcrp1 mediated efflux with canertinib or erlotinib. Int J Pharm 2012;436:127-34
   PubMed Web of Science ®Google Scholar
• VOTRIENT ® (pazopanib). GlaxoSmithKline; Research Triangle Park, NC: 2012
   Google Scholar
• Iwamoto FM, Lamborn KR, Robins HI, et al. Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02). Neuro Oncol 2010;12:855-61
   PubMed Web of Science ®Google Scholar